BURLINGTON, Mass., Nov. 04, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in four investor conferences in November.
George W. LeMaitre, Chairman & CEO, is scheduled to present at the Brean Capital Life Sciences Summit in New York on Monday, November 16 at the Millenium Broadway Hotel. He is also scheduled to present at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum in New York on Thursday, November 19 at the Westin Grand Central Hotel, at 3:30 pm ET.
David Roberts, President, is scheduled to present at the Stifel Healthcare Conference on Tuesday, November 17 at the New York Palace Hotel in New York. The Company's presentation is scheduled to begin at 1:30 pm ET.
Beth Kurth, Investor Relations, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference on Wednesday, November 18 at the Marriott Quorum, Dallas, TX. The Company’s presentation is scheduled to begin at 2:10 pm ET.
For more information or to register, please visit the conference websites at www.breancapital.com, www.canaccordgenuity.com, www.stifel.com and www.threepartadvisors.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.Beth Kurth
LeMaitre Vascular, Inc.